| Affiliation: | 1. Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450000, China;2. Nanchang University Queen Mary School, Nanchang 330000, China;3. Medical Engineering Technology and Data Mining Institute of Zhengzhou University, Zhengzhou 450000, China |
| Abstract: | ObjectiveTo compare and analyze three therapies on patients with primary central nervous system lymphoma (PCNSL), aiming to provide evidences for future treatment and prognosis.MethodsClinical data of 26 cases of PCNSL with normal immune system confirmed by postoperative pathology were retrospectively analyzed. Among them there were six cases with operation only, nine cases with operation and radiotherapy, and 11 cases with operation, radiotherapy and chemotherapy, and their survival rate was compared as well.ResultsThe survival time of patients with operation only, operation combined with radiotherapy and operation combined with radiotherapy and chemotherapy was 6–11?months, 15–24?months and 24–51?months, respectively. And their median survival time was only nine months, 21?months and 38?months, respectively.ConclusionsOperation combined with radiotherapy and chemotherapy can dramatically extend PCNSL patients’ survival time, therefore, it can be regarded as the first-line therapy. |
